Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer

Figure 7

Functional study of EIF3J-AS1 via in vitro experiments from public datasets. (a) EIF3J-AS1 was downregulated after E2 treatment in breast cancer cell line MCF7. (b) EIF3J-AS1 was upregulated after siERa experiments in MCF7. (c) The expression of EIF3J-AS1 decreased after FDI-6 treatment. (d) CCNB1 is coexpressed with EIF3J-AS1. The expression of CCNB1 decreased after FDI-6 treatment.

(a)

(b)

(c)

(d)